Organ-on-a-Chip market projected to reach USD 1.64 billion by 2032, driven by various factors.
From GlobeNewswire: 2025-04-02 09:40:00
The Organ-on-a-Chip market is booming, with a value of USD 117.67 million in 2023 and projected to reach USD 1,641.51 million by 2032, growing at a CAGR of 34.04%. This growth is driven by the demand for accurate drug testing, microfluidics technology advancements, and a shift towards reducing animal testing. The market is revolutionizing drug discovery with microengineered systems mimicking human organ function, leading to more precise drug evaluation and toxicity assessment. The United States is a key player in adopting Organ-on-a-Chip technology, with significant investments from both governmental agencies and private organizations to speed up drug development and reduce reliance on animal models. Personalized medicine and stringent regulations are also driving the adoption of Organ-on-a-Chip platforms in various industries. The market is segmented by products & services, applications, model types, purposes, and end-users, with a focus on drug discovery and toxicology research. North America dominated the market in 2023, with the Asia-Pacific region expected to grow rapidly due to increased investments in healthcare infrastructure and a focus on pharmaceutical R&D. Recent developments include OrganOx securing USD 142 million for expansion, Emulate Inc. collaborating with the FDA for liver-on-chip models, and CN Bio raising USD 21 million in funding. In March 2024, MIMETAS secured funding to boost product development for Organ on a Chip (OOC) solutions due to increased demand from drug R&D advancements and regulatory changes like the US FDA Modernization Act 2.0. This is part of a larger initiative supported by the Dutch National Growth Fund worth €124 million, aiming to promote animal-free biomedical innovations. In October 2024, scientists at the University of the Basque Country (UPV) developed artificial skin using OOC technology to eliminate animal testing in drug development, enhancing ethical standards and improving preclinical study accuracy.
Read more at GlobeNewswire: Organ-on-a-Chip Market Projected to Hit USD 1.64 Billion by